Posted in General Business 30+ days ago.
Type: Full-Time
Location: Cambridge, Massachusetts
Scientist: Discovery & Translational Research
Overview
Alnylam is the world's leading RNA interference (RNAi) company.
Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality by harnessing the power of RNAi for human health as an innovative new class of medicines. We are a growing biopharmaceutical company with three approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.
Headquartered in Cambridge, Mass., Alnylam employs over 1,500 people in 19 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work six years in a row (2015-2020), a Great Place to Work in the U.K. and Switzerland two years in a row (2019-2020) and a Science Magazine's Top Employer two years in a row (2019-2020). Please visit www.alnylam.com for more information.
Discovery and Translational Research group at Alnylam is seeking a motivated and knowledgeable Scientist in the liver targets space. This individual will join a multidisciplinary group that identifies, validates, and develops drug candidates form an idea to clinic. The responsibilities will include, understanding of disease biology, leadership of the Lead development process, as well as identification and validation of novel drug targets.
Summary of Key Responsibilities
Beacon Hill Staffing Group, LLC
|
Beacon Hill Staffing Group, LLC
|
Kforce Inc
|